Multidisciplinary Association For Psychedelic Studies
Add to my favorites Added to favorites!
Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy
Someone who had 3 hours of volunteer time could: Volunteers could help us raise funds by tabling at events and passing our information on to potential donors. We also always need help with office-related tasks such as writing, proofreading, data entry, etc.
Geographic areas served: Worldwide
Mission:
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
MAPS furthers its mission by:
-Developing psychedelics and marijuana into prescription medicines
-Training therapists and working to establish a network of treatment centers
-Supporting scientific research into spirituality, creativity, and neuroscience
-Educating the public honestly about the risks and benefits of psychedelics and marijuana
MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.
MAPS furthers its mission by:
-Developing psychedelics and marijuana into prescription medicines
-Training therapists and working to establish a network of treatment centers
-Supporting scientific research into spirituality, creativity, and neuroscience
-Educating the public honestly about the risks and benefits of psychedelics and marijuana
MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.
Results:
MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.
Invite reviews
Invite friends and colleagues to share their experiences with this nonprofit
639 Reviews
See all »
Write A Review
See all »
MAPS has been diclosing the tabu of psychoactive substance adaptive consumption. They have been facing immense legal, political and financal challanges and proved themselve to be patient, tireless and competent. After many years of their activiy we have here several rigorous psychedelic studies done...
more »
chrismraymond
Review from Guidestar
11/30/12
Support This Nonprofit
Promote This Nonprofit
Great Nonprofits badges allow you to raise awareness of your favorite organizations on your own web sites. for text link or graphic badge.
Get badge